IDEAYA Biosciences, Inc. (IDYA)

NMS – Цена в реальном времени. Валюта: USD

36.96

+0.12 (0.33%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

36.96

0.00 (0.00%)

После закрытия: Aug 12, 2026, 4:20 PM EDT

04.08.2026

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing is underway under the real-time oncology review program (RTOR) with completion expected in H2 2026 Updated data from Phase 2 OptimUM-01 trial (HLA*A2-positive mUM patient subset) and Phase 2 OptimUM-09 trial (neoadjuvant primary UM) to be presented at ESMO Updated data from Hengrui-sponsored Phase 1 trial of IDE849 (DLL3 TOP1 ADC) in small-cell lung cancer (SCLC) and neuroendocrine carcinomas (NEC) patients to be presented at ESMO Announced clinical collaboration with Roche to evaluate IDE892 (PRMT5) in combination with RG6505 (pan-RAS) in MTAP-deleted, RAS-mutant pancreatic cancer; targeting to initiate a Phase 1 combination trial in H2 2026 IDEAYA to host an R&D Day in Q4 focused on MTAP/CDKN2A, KRAS, and pancreatic cancer ~$1.24 billion of cash, cash equivalents, and marketable securities as of June 30, 2026; cash runway guidance into 2030 is unchanged based on current operating plan SOUTH SAN FRANCISCO, Calif., Aug. 4, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery, development and commercialization of targeted therapeutics, today reported financial results for the second quarter ended June 30, 2026, and provided a business update.

Видео

No Data

There is no data to display

Пресс-релизы

04.08.2026

IDEAYA Biosciences, Inc. (IDYA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Search stocks

IDEAYA Biosciences, Inc. (IDYA)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Видео

No Data

Пресс-релизы

IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update